PL2950783T3 - Sztuczne łzy zawierające hialuronian sodu oraz karboksymetylocelulozę - Google Patents

Sztuczne łzy zawierające hialuronian sodu oraz karboksymetylocelulozę

Info

Publication number
PL2950783T3
PL2950783T3 PL14704747T PL14704747T PL2950783T3 PL 2950783 T3 PL2950783 T3 PL 2950783T3 PL 14704747 T PL14704747 T PL 14704747T PL 14704747 T PL14704747 T PL 14704747T PL 2950783 T3 PL2950783 T3 PL 2950783T3
Authority
PL
Poland
Prior art keywords
carboxymethylcellulose
sodium hyaluronate
artificial tears
tears
artificial
Prior art date
Application number
PL14704747T
Other languages
English (en)
Inventor
Bereth J Beard
Wendy M Blanda
David A Marsh
Peter A Simmons
Joseph G Vehige
Liu Haixia
Steven S Matsumoto
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of PL2950783T3 publication Critical patent/PL2950783T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
PL14704747T 2013-02-01 2014-02-03 Sztuczne łzy zawierające hialuronian sodu oraz karboksymetylocelulozę PL2950783T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361759710P 2013-02-01 2013-02-01
US201361785857P 2013-03-14 2013-03-14
EP14704747.6A EP2950783B1 (en) 2013-02-01 2014-02-03 Artificial tears comprising sodium hyaluronate and carboxymethylcellulose
PCT/US2014/014505 WO2014121232A1 (en) 2013-02-01 2014-02-03 Artificial tears comprising sodium hyaluronate and carboxymethylcellulose

Publications (1)

Publication Number Publication Date
PL2950783T3 true PL2950783T3 (pl) 2019-11-29

Family

ID=50113045

Family Applications (2)

Application Number Title Priority Date Filing Date
PL14704747T PL2950783T3 (pl) 2013-02-01 2014-02-03 Sztuczne łzy zawierające hialuronian sodu oraz karboksymetylocelulozę
PL19151359T PL3517100T3 (pl) 2013-02-01 2014-02-03 Sztuczne łzy zawierające hialuronian sodu oraz karboksymetylocelulozę

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL19151359T PL3517100T3 (pl) 2013-02-01 2014-02-03 Sztuczne łzy zawierające hialuronian sodu oraz karboksymetylocelulozę

Country Status (24)

Country Link
US (3) US20140221309A1 (pl)
EP (2) EP2950783B1 (pl)
JP (2) JP6527468B2 (pl)
KR (1) KR102227202B1 (pl)
CN (2) CN111419794A (pl)
AU (2) AU2014212025A1 (pl)
BR (1) BR112015018414B1 (pl)
CA (1) CA2898217C (pl)
CY (1) CY1124054T1 (pl)
DK (2) DK2950783T3 (pl)
ES (2) ES2841434T3 (pl)
HK (1) HK1218517A1 (pl)
HR (1) HRP20191382T1 (pl)
HU (2) HUE052793T2 (pl)
LT (1) LT2950783T (pl)
MX (1) MX367461B (pl)
PL (2) PL2950783T3 (pl)
PT (2) PT2950783T (pl)
RS (1) RS59271B1 (pl)
RU (1) RU2687275C2 (pl)
SA (1) SA517381008B1 (pl)
SI (2) SI3517100T1 (pl)
WO (1) WO2014121232A1 (pl)
ZA (1) ZA201505026B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015006460A1 (en) 2013-07-10 2015-01-15 Matrix Biology Institute Compositions of hyaluronan with high elasticity and uses thereof
US9694084B2 (en) 2014-12-23 2017-07-04 Dana-Farber Cancer Institute, Inc. Methods to induce targeted protein degradation through bifunctional molecules
US20170014339A1 (en) * 2015-07-17 2017-01-19 i.com medical GmbH Tear Substitute, Fluid for Being Used as a Tear Substitute, and Method for Producing a Tear Substitute
EP3352766B1 (en) 2015-09-24 2021-03-17 Matrix Biology Institute High elasticity hyaluronan compositions and methods of use thereof
WO2017075019A1 (en) * 2015-10-28 2017-05-04 Welch David B Eye drops
ES2621877B1 (es) * 2016-01-04 2018-05-04 Agencia Pública Empresarial Sanitaria Hospital De Poniente Solución para resección endoscópica
US10632202B2 (en) * 2016-03-04 2020-04-28 Johnson & Johnson Consumer Inc. Preservative containing compositions
GB201618175D0 (en) * 2016-10-27 2016-12-14 Warneford Healthcare Ltd Pharmaceutical compositions
EP3412276A3 (de) * 2017-06-09 2019-07-17 Omnivision GmbH Zusammensetzung zur behandlung des trockenen auges
WO2020057548A1 (en) * 2018-09-20 2020-03-26 The Hong Kong University Of Science And Technology Eyedrop compositions
KR102051356B1 (ko) * 2019-01-03 2019-12-03 (주)휴온스 고농도의 히알루론산 또는 그의 염을 함유하는 점안 조성물
MX2023010372A (es) 2021-03-10 2023-09-12 Bausch Lomb Ireland Ltd Soluciones oftálmicas.

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017229A (en) 1990-06-25 1991-05-21 Genzyme Corporation Water insoluble derivatives of hyaluronic acid
US6271216B1 (en) * 1989-07-24 2001-08-07 Allergan Stable solution of hyaluronate in a balanced salt medium
AU773826B2 (en) * 1999-02-19 2004-06-10 Denki Kagaku Kogyo Kabushiki Kaisha Hyaluronic acid gel composition, process for producing the same, and medical material containing the same
JP2002539157A (ja) 1999-03-15 2002-11-19 トラスティーズ オブ ボストン ユニバーシティ 血管新生阻害
MXPA02004701A (es) * 1999-11-09 2004-09-10 Alcon Inc Sales de hidroxieicosatetraenoato, composiciones y metodos de uso para tratar trastornos de resequedad en los ojos.
CA2393354A1 (en) * 1999-12-17 2001-06-21 Timothy J. Butler Surgical prosthesis
CN1485395A (zh) * 2002-09-25 2004-03-31 宋海涛 一种环保型“冷热液”
US20040137079A1 (en) * 2003-01-08 2004-07-15 Cook James N. Contact lens and eye drop rewetter compositions and methods
JP2006052160A (ja) * 2004-08-10 2006-02-23 Rohto Pharmaceut Co Ltd ドライアイ治療用眼科組成物
JP2006143590A (ja) * 2004-10-21 2006-06-08 Rohto Pharmaceut Co Ltd 粘膜適用組成物
SG157374A1 (en) * 2004-11-09 2009-12-29 Abbott Medical Optics Inc Ophthalmic solution
US8569367B2 (en) * 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
KR20090053892A (ko) * 2006-07-25 2009-05-28 오스모티카 코프. 점안액
KR101454041B1 (ko) * 2006-11-06 2014-10-27 노파르티스 아게 안구 장치 및 그의 제조 및 사용 방법
US8609634B2 (en) * 2007-05-16 2013-12-17 Mcneil-Ppc, Inc. Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods
KR100827400B1 (ko) * 2008-06-24 2008-05-06 김정춘 파이프 연결구를 갖는 수도계량기 및 그 제조방법
KR100938500B1 (ko) * 2008-06-24 2010-01-28 주식회사 디에이치피코리아 안과질환 예방 및 치료용 점안제 조성물
US20100086512A1 (en) 2008-10-02 2010-04-08 Rolf Schaefer Mucomimetic compositions and uses therefore
AU2009308017A1 (en) * 2008-10-20 2010-04-29 Allergan, Inc. Ophthalmic compositions useful for improving visual acuity
CN104906580A (zh) * 2009-12-15 2015-09-16 前瞻生物治疗公司 无刺激性眼科聚维酮碘组合物
CN101785852A (zh) * 2010-01-21 2010-07-28 孙杰 一种真皮层微量介入美容抗衰除皱制剂与方法
CN101884602A (zh) * 2010-03-03 2010-11-17 孙杰 一种皮肤美容修复抗衰除皱的化妆品制剂

Also Published As

Publication number Publication date
ES2741141T3 (es) 2020-02-10
JP2019112411A (ja) 2019-07-11
AU2018260857A1 (en) 2018-11-22
BR112015018414A2 (pt) 2017-07-18
KR102227202B1 (ko) 2021-03-12
CN104981234A (zh) 2015-10-14
WO2014121232A1 (en) 2014-08-07
US20160235780A1 (en) 2016-08-18
LT2950783T (lt) 2019-10-25
CY1124054T1 (el) 2022-03-24
EP2950783B1 (en) 2019-05-15
EP3517100B1 (en) 2020-09-09
RU2015132974A (ru) 2017-03-06
JP6876079B2 (ja) 2021-05-26
EP3517100A1 (en) 2019-07-31
CA2898217C (en) 2021-08-31
US20220096531A1 (en) 2022-03-31
BR112015018414B1 (pt) 2022-11-08
ZA201505026B (en) 2016-07-27
RU2687275C2 (ru) 2019-05-13
ES2841434T3 (es) 2021-07-08
EP2950783A1 (en) 2015-12-09
AU2018260857B2 (en) 2020-05-07
CN111419794A (zh) 2020-07-17
RS59271B1 (sr) 2019-10-31
MX367461B (es) 2019-08-21
DK2950783T3 (da) 2019-07-22
PT2950783T (pt) 2019-08-21
PT3517100T (pt) 2020-12-15
HUE044555T2 (hu) 2019-11-28
MX2015009924A (es) 2015-09-25
CA2898217A1 (en) 2014-08-07
SI3517100T1 (sl) 2021-02-26
HK1218517A1 (zh) 2017-02-24
SI2950783T1 (sl) 2019-10-30
PL3517100T3 (pl) 2021-04-19
SA517381008B1 (ar) 2019-08-31
HRP20191382T1 (hr) 2019-11-15
HUE052793T2 (hu) 2021-05-28
US20140221309A1 (en) 2014-08-07
AU2014212025A1 (en) 2015-08-20
DK3517100T3 (da) 2020-12-14
JP2016507529A (ja) 2016-03-10
KR20150113156A (ko) 2015-10-07
JP6527468B2 (ja) 2019-06-05

Similar Documents

Publication Publication Date Title
HK1218517A1 (zh) 包含透明質酸鈉和羧甲基纖維素的人工淚液
HK1213961A1 (zh) 鉸鏈
EP2948519A4 (en) DELAYED GELIFYING AGENTS
HK1222664A1 (zh) 硫酸乙酰肝素
HK1217452A1 (zh) 含有前列腺胺的眼内植入物
EP2986798A4 (en) HINGE
EP2987933A4 (en) HINGE
SG11201505267SA (en) Jctvc-l0226: vps and vps_extension updates
HK1222572A1 (zh) 包含膠原和透明質酸鈉的藥物組合物
GB201304837D0 (en) Implant trialling
GB2520480B (en) Improvements in hinge assemblies
PL2978326T3 (pl) Papierosy i ich budowa
HK1221906A1 (zh) 硫酸乙酰肝素
GB201304835D0 (en) Implant trialling
GB201421052D0 (en) Artificial tissue
HK1223555A1 (zh) 用於減少眼內壓的組合物和方法
GB201303796D0 (en) Condom
GB201303131D0 (en) Ocular prosthesis
GB2517211B (en) Conformable tissue expander
EP3003323A4 (en) POLYSACCARIDE COMPOSITIONS AND CORRESPONDING METHODS
ZA201407945B (en) Hinge arrangement
GB201321018D0 (en) Improvements in hinge assemblies